Medical Devices Startups
6,526 companies tagged Medical Devices, with their investors and founders.
Cyrcadia Health develops technology based on circadian rhythm science to detect tissue disruption and cancer risk. The company's core innovation relates circadian clock dysregulation to cancer development and prognosis.
0 investors
CytoDyn is a biopharmaceutical company conducting clinical trials, including a Phase 2 colorectal cancer trial.
0 investors
Cytonics develops biologic therapies targeting osteoarthritis, with lead candidate CYT-108, a recombinant protease inhibitor for knee joint regeneration based on a novel pathway to restore cartilage-secreting cells. The company funds development through equity crowdfunding from individual investors rather than venture capital.
0 investors
Diagnostic Biochips develops multichannel neural probes for extracellular recording in electrophysiology research, along with cloud-based software for spike sorting and analysis. It serves neuroscience researchers studying the brain at the neural network level.
0 investors
Diality is a medical device company developing a home hemodialysis machine and related solutions for patients with kidney disease, aimed at supporting new decentralized kidney-care models. The Series-B company serves the dialysis and nephrology market and is based in Irvine, California.
0 investors
Diceros Therapeutics develops Verasone, a drug candidate combining two existing therapies for treatment of chronic rhinosinusitis via sinonasal irrigation. The company is advancing the treatment through clinical trials to provide improved efficacy and reduced side effects compared to existing options.
0 investors
Digitx Partners is a venture capital firm focused on identifying and supporting digital health and medical device companies with growth potential and technologies that advance healthcare innovation. The firm invests in non-invasive medical devices and software solutions designed to improve patient outcomes and healthcare delivery.
0 investors
Dilon Technologies is a medical device manufacturer that develops surgical instruments and diagnostic tools for healthcare practitioners, including gamma probes for lymphatic mapping, margin assessment devices for breast cancer surgery, and video laryngoscopes.
0 investors
Direct Allergy provides on-site allergy testing and immunotherapy services for physicians' practices, using Modified Quantified Testing skin testing and formulating individualized immunotherapy treatments. The company serves medical practices across the United States.
0 investors
Diverse Biotech develops novel synthetic cannabinoid compounds and drug conjugate therapies aimed at cancer treatment. The company operates in the pharmaceutical and biotech sector with a focus on oncology therapeutics.
0 investors
Double Blind Bio builds AI agents that automate administrative workflows within clinical trial sites and sponsor operations, enabling faster and more efficient execution of clinical studies. The company targets research sites and trial sponsors who seek to reduce repetitive work and accelerate patient access to new treatments.
0 investors
Dragonfly Endoscopy develops a fully rotatable 360° pancreaticobiliary endoscope with refined optics, precision control, and therapeutic capabilities for cholangiopancreatoscopy. The company makes medical devices for treating pancreaticobiliary disease and has received FDA 510(k) clearance for its scope.
0 investors
DurVena is developing a photochemical tissue passivation therapy that treats harvested veins to strengthen tissue and improve long-term vein graft durability. The company targets vascular surgery applications where vein grafts are used for reconstructive procedures.
0 investors
Dynocardia develops ViTrack, a wearable and connected platform for continuous monitoring of blood pressure and other vital heart and lung functions. The technology targets applications across hospitals, clinical practice, remote patient monitoring, and consumer wellness.
0 investors
EchoNous develops Point-of-Care ultrasound (POCUS) systems, centered on its handheld Kosmos device, which combines portable ultrasound hardware with proprietary deep learning AI for clinical use including cardiac, bladder, and vascular access applications. Its products serve clinicians and healthcare providers, with devices manufactured in the United States.
0 investors
ECM Therapeutics is a regenerative medicine company that develops and manufactures therapeutic products derived from extracellular matrix (ECM), a naturally occurring material that influences cell behavior, controls inflammation, and supports tissue restoration after injury. Its platform is based on extracellular matrix science and an associated patent portfolio.
0 investors
Ecogenome performs molecular genetic testing of individual patients' tumors to identify therapeutic vulnerabilities and guide cancer therapy planning. The company focuses on the molecular genetics of treatment-resistant cancers.
0 investors
Efemoral Medical is an early-stage medical technology company developing minimally invasive treatments for patients with peripheral vascular disease. Its solutions target a condition affecting an estimated 200 million people worldwide.
0 investors
ElectroCyt develops handheld diagnostic devices and health data infrastructure to enable frequent, accessible disease testing and early detection before symptoms appear. The company targets patients and healthcare providers seeking preventive medicine solutions through devices like LifeCounts, a portable blood count analyzer.
0 investors
Eleven P15 is a company focused on the genetics of pulmonary fibrosis, with work spanning biomarker development, genomics, and animal models of human disease.
0 investors
Eliaz Therapeutics develops XGal-3, an investigational therapeutic apheresis device that uses an antibody-based resin to remove the protein Galectin-3 from the bloodstream. It targets Galectin-3 as a driver of sepsis, cancer, heart disease, fibrosis, and kidney disease, and is in the preclinical and first-in-human study stage.
0 investors
Emboline develops the Emboliner Embolic Protection System, a cerebral protection device aimed at preventing stroke during transcatheter aortic valve replacement (TAVR) procedures. The company serves interventional cardiologists in the structural heart and cardiovascular medical device market.
0 investors
Emmaus Life Sciences is a pharmaceutical company that develops and commercializes Endari (prescription-grade L-glutamine oral powder), an FDA-approved treatment for sickle cell disease, and pursues additional indications such as diverticulosis. The company sells and seeks marketing authorization for its products in the United States and internationally, including the Middle East and North Africa region.
0 investors
Enalare Therapeutics is a clinical-stage biopharmaceutical company developing therapies for patients with acute respiratory conditions. It works to advance its drug products through development, regulatory review, and launch.
0 investors